Bioforce Nanosciences Holdings, Inc.
BFNH- Exchange
- OTC
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001310488
In the last 90 days, Bioforce Nanosciences Holdings, Inc. insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of BFNH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bioforce Nanosciences Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nexus Capital Investments, Inc. | 13D | 79.60%26.7M shares | New | Sep 4, 20261 filing | Sep 4, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Bioforce Nanosciences Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 20262:38 PM ET | Nexus Capital Investments, Inc. | 13D | 79.60%26.7M shares | New | Apr 22, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bioforce Nanosciences Holdings, Inc. shares.
No Form 144 notices for Bioforce Nanosciences Holdings, Inc. are on file.